These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3354559)

  • 1. Altered platelet deformability in patients with type IIa and type IV hyperlipoproteinemia.
    Smith CM; Burris SM; Hunninghake DB; White JG
    Am J Hematol; 1988 Apr; 27(4):247-52. PubMed ID: 3354559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Platelet half-life in patients with primary hyperlipoproteinemia type IIa, IIb, and IV according to Fredrickson with and without clinical signs of atherosclerosis].
    Jäger E; Sinzinger H; Widhalm K; Kaliman J; Höfer R
    Wien Klin Wochenschr; 1982 Sep; 94(16):421-5. PubMed ID: 7147981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rheological properties and membrane fluidity of red blood cells and platelets in primary hyperlipoproteinemia.
    Muller S; Ziegler O; Donner M; Drouin P; Stoltz JF
    Atherosclerosis; 1990 Aug; 83(2-3):231-7. PubMed ID: 2242099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of type IIa, IIb and IV-hyperlipoproteinemia on platelet prostaglandin sensitivity, plasma thromboxane B2 and platelet half-life.
    Strobl-Jäger E; Widhalm K; Sinzinger H
    Prostaglandins Leukot Med; 1986 Nov; 25(1):39-47. PubMed ID: 3540998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet membrane fluidity in type IIA, type IIB and type IV hyperlipoproteinemia.
    Malle E; Sattler W; Prenner E; Leis HJ; Karàdi I; Knipping G; Romics L; Kostner GM
    Atherosclerosis; 1991 Apr; 87(2-3):159-67. PubMed ID: 1854362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hyperlipoproteinemia, types II and IV, with pirifibrate: one hundred observations.
    Bonora V; Calalabuig RJ; Caviola E; Soler J; Pueyo JM; Micaló T; Cano RP
    Clin Ther; 1981; 4(3):192-200. PubMed ID: 7030489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of oxandrolone on plasma lipoproteins in patients with type IIa, IIb and IV hyperlipoproteinemia: occurrence of hypo-high density lipoproteinemia.
    Tamai T; Nakai T; Yamada S; Kobayashi T; Hayashi T; Kutsumi Y; Takeda R
    Artery; 1979 Feb; 5(2):125-43. PubMed ID: 231951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma cholesterol esterification rate in hyperlipoproteinaemia: relation to cholesterol elimination.
    Angelin B; Einarsson K; Leijd B; Wallentin L
    Scand J Clin Lab Invest; 1988 Sep; 48(5):481-7. PubMed ID: 3206195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased number of PGD2 binding sites on platelets from patients with type IIa hyperlipoproteinemia.
    Abbate R; Modesti PA; Fortini A; Lombardi A; Matucci M; Gensini GF; Neri Serneri GG; Fellin R; Valerio G; Crepaldi G
    Atherosclerosis; 1985 Feb; 54(2):167-75. PubMed ID: 3857047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pirifibrate in the treatment of hyperlipoproteinemia: types IIa, IIb, and IV.
    Lopez Rodriguez J; Martorell J
    Clin Ther; 1980; 3(4):234-41. PubMed ID: 7273061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of bezafibrate on serum lipid, lipoprotein and apoprotein levels in patients with hyperlipoproteinemia type II and IV].
    Bednarska-Makaruk M; Kuźmińska A; Chotkowska E; Kurjata P; Polakowska M; Broda G; Rywik S
    Pol Arch Med Wewn; 1992 Mar; 87(3):149-56. PubMed ID: 1523145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Quantitative analysis of lipoproteins in hyperlipoproteinemias of type IIa, IIb and IV (author's transl)].
    Loeper J; Goy-Loeper J; Rouffy J
    Clin Chim Acta; 1979 Oct; 98(1-2):19-26. PubMed ID: 227624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fatty acid metabolism in primary hyperlipoproteinemia (HLP) (author's transl)].
    Reuter W
    Dtsch Z Verdau Stoffwechselkr; 1979; 39(3):124-9. PubMed ID: 520271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lathosterol level in plasma is elevated in type III hyperlipoproteinemia, but not in non-type III subjects with apolipoprotein E2/2 phenotype, nor in type IIa or IIb hyperlipoproteinemia.
    Kempen HJ; Gevers Leuven JA; van der Voort HA; de Knijff P; Havekes L
    Metabolism; 1991 Mar; 40(3):231-5. PubMed ID: 2000034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Subfractions of HDL cholesterol. Occurrence in hyperlipoproteinemia type IIa and IV].
    Mertz DP; Thuilot G; Bürvenich K
    Fortschr Med; 1986 Jul; 104(26):508-10. PubMed ID: 3744260
    [No Abstract]   [Full Text] [Related]  

  • 16. Distribution of actin, myosin and actin binding protein in platelets of patients with hyperlipoproteinemia.
    Eldor A; Kahane I; Yatziv S; Fainaru M; Muhlrad A
    Thromb Res; 1983 Jul; 31(1):155-62. PubMed ID: 6612694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet function and platelet lipid composition in the dyslipoproteinemias.
    Shastri KM; Carvalho AC; Lees RS
    J Lipid Res; 1980 May; 21(4):467-72. PubMed ID: 7381337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Functional status of thrombocytes and the anti-aggregative activity of the vascular wall in dyslipoproteinemias and ischemic heart disease].
    Mikhailova IA; Lipovetskiĭ BM; Magracheva EIa; Gurevich VS
    Ter Arkh; 1989; 61(2):101-4. PubMed ID: 2727909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormalities of cholesterol-phospholipid composition in platelets and low-density lipoproteins of human hyperbetalipoproteinemia.
    Shattil SJ; Bennett JS; Colman RW; Cooper RA
    J Lab Clin Med; 1977 Feb; 89(2):341-53. PubMed ID: 188956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum lipoprotein composition in different types of hyperlipoproteinemia.
    Carlson LA
    Adv Exp Med Biol; 1975; 63():185-99. PubMed ID: 173148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.